Modular Medical (MODD) Long-Term Deferred Tax (2022 - 2023)

Modular Medical (MODD) reported Long-Term Deferred Tax of $14.9 million for Q1 2023, up 41.96% on a YoY basis from $10.5 million in Q1 2022, and up 41.96% quarter-over-quarter from $10.5 million in Q1 2022.

Modular Medical (MODD) Long-Term Deferred Tax (2022 - 2023) Analysis & Trends

Modular Medical has reported Long-Term Deferred Tax for 2 years, with the latest figure at $14.9 million in Q1 2023.

  • For the quarter ending Q1 2023, Long-Term Deferred Tax rose 41.96% year-over-year to $14.9 million; the trailing twelve-month figure through Mar 2023 stood at $14.9 million (up 41.96% YoY), and the FY2023 full-year result was $14.9 million, up 41.96% from the prior year.
  • Long-Term Deferred Tax for Q1 2023 stood at $14.9 million, up from $10.5 million in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $14.9 million in Q1 2023, with the low at $10.5 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Modular Medical 9.30 Mn 6.36 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 14.93 Mn
Mar 31, 2022 10.52 Mn